Clinical and Immunologic Aspects of Rheumatoid Arthritis with a Focus on IL-6

http://academiccme.com/wp-content/uploads/2016/01/Screen-Shot-2015-10-02-at-10.44.09-AM.png

Course Information

Therapautic Area: Rheumatology
Format(s): Webcast, Downloadable Transcript
Credit(s): 1.00 AMA PRA Category 1 Credit(s)™
Activity Dates: December 1, 2015 - July 1, 2017

 

Program Overview

This CME activity will provide physicians and other medical care professionals who aid in the treatment of rheumatoid arthritis the most up-to-date information on treatment guidelines and clinical trial data. Dr. Epstein will evaluate the newly updated ACR/EULAR treatment guidelines and aid physicians on how to incorporate them into their practice. The mechanisms of action of new and emerging therapies will be evaluated in order to give a better understand of the treatment. The role of IL-6 in rheumatoid arthritis and recent clinical trial data in this area will be reviewed. Physicians will be able to incorporate the latest developments in RA into personalized treatment plans when treating patients upon completion of this course.

Target Audience

Rheumatologists/immunology specialists, primary care physicians, and other healthcare professionals who care for patients with RA

Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Evaluate newly updated ACR/EULAR treatment guidelines.
  2. Analyze the mechanisms of action for available and emerging therapeutics and in development for the treatment of RA, including associated clinical trial data.
  3. Integrate therapeutic selection guidelines and patient management strategies into the development of personalized treatment plans in RA.

 

Faculty

Alan L. Epstein, MD
Associate Professor of Medicine
University of Pennsylvania
School of Medicine
Philadelphia, PA

Disclosure of Conflicts of Interest

It is the policy of AcademicCME that all faculty, instructors, and planners disclose real or apparent conflicts of interest relating to the topics of this educational activity.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Faculty Relationship Identified With:
Alan L. Epstein, MD Speaker’s Bureau: AbbVie, Inc.; Antares Pharma; Bristol-Myers Squibb Company; Crescendo Bioscience, Inc; Genentech, Inc; Janssen Global Services, LLC; and Pfizer Inc.

Non-faculty

Timothy Hayes, MD, PhD; Kristen Scollon; Emma Gilmartin and Nicole Brestowski hereby state that they or their spouse/life partner do not have any financial relationships to products or devices with any commercial interests related to the content of this activity of any amount during the past 12 months.

Accreditation Statement

AcademicCME is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement

AcademicCME designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Financial Support

This activity has been supported by an independent educational grant from Sanofi US Services, Inc.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. AcademicCME and Sanofi US Services, Inc. do not recommend the use of any agent outside of the labeled indications.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Method of Participation

In order to claim credit, participants must complete the following:

  1. Read the learning objectives, accreditation information and faculty disclosures at the beginning of this activity.
  2. Complete the Pre-Activity Questions
  3. Read or Review the activity content.
  4. Complete the Post-Activity Test Questions and Evaluation.
  5. Physicians who receive a grade of 70% or better on the Post-Activity Test Questions and who complete the Evaluation will receive a CME Certificate.
  6. All other participants who receive a grade of 70% or better on the Post-Activity Test Questions and who complete the Evaluation will receive a Certificate of Participation.

CME INQUIRIES/SPECIAL NEEDS

For all CME inquiries or special needs, please contact admin@academiccme.com.

BUTTON